These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 26438346)

  • 1. "Short term surgical complications after subthalamic deep brain stimulation for Parkinson's disease: does old age matter?".
    Levi V; Carrabba G; Rampini P; Locatelli M
    BMC Geriatr; 2015 Oct; 15():116. PubMed ID: 26438346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.
    Paek SH; Han JH; Lee JY; Kim C; Jeon BS; Kim DG
    Neurosurgery; 2008 Nov; 63(5):925-36; discussion 936-7. PubMed ID: 19005383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients.
    Tir M; Devos D; Blond S; Touzet G; Reyns N; Duhamel A; Cottencin O; Dujardin K; Cassim F; Destée A; Defebvre L; Krystkowiak P
    Neurosurgery; 2007 Aug; 61(2):297-304; discussion 304-5. PubMed ID: 17762742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staged bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
    Tanei T; Kajita Y; Kaneoke Y; Takebayashi S; Nakatsubo D; Wakabayashi T
    Acta Neurochir (Wien); 2009 Jun; 151(6):589-94. PubMed ID: 19381434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of the deep brain stimulation impairment scale (DBS-IS).
    Maier F; Lewis CJ; Eggers C; Kühn AA; Krug H; Volkmann J; Kirsch AD; Wojtecki L; Schnitzler A; Deuschl G; Krauss JK; Woopen C; Timmermann L
    Parkinsonism Relat Disord; 2017 Mar; 36():69-75. PubMed ID: 28089264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-operative obesity may influence subthalamic stimulation outcome in Parkinson's disease.
    Rouillé A; Derrey S; Lefaucheur R; Borden A; Fetter D; Jan M; Maltête D
    J Neurol Sci; 2015 Dec; 359(1-2):260-5. PubMed ID: 26671125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of white matter lesions on the cognitive outcome of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Blume J; Lange M; Rothenfusser E; Doenitz C; Bogdahn U; Brawanski A; Schlaier J
    Clin Neurol Neurosurg; 2017 Aug; 159():87-92. PubMed ID: 28582689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the effects of unilateral electrode dysfunction in patients with Parkinson disease undergoing bilateral subthalamic nucleus deep brain stimulation.
    Park YS; Kim JP; Chang WS; Lee PH; Sohn YH; Chang JW
    Neurosurgery; 2012 Mar; 70(1 Suppl Operative):163-9; discussion 169. PubMed ID: 21768919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Parkinson's disease on a probabilistic Go/NoGo task deep brain stimulation of the subthalamic nucleus only interferes with withholding of the most prepotent responses.
    Georgiev D; Dirnberger G; Wilkinson L; Limousin P; Jahanshahi M
    Exp Brain Res; 2016 Apr; 234(4):1133-43. PubMed ID: 26758720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.
    Lefaucheur JP; Gurruchaga JM; Pollin B; von Raison F; Mohsen N; Shin M; Ménard-Lefaucheur I; Oshino S; Kishima H; Fénelon G; Rémy P; Cesaro P; Gabriel I; Brugières P; Keravel Y; Nguyen JP
    Eur Neurol; 2008; 60(4):186-99. PubMed ID: 18667827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease.
    Greenbaum L; Israeli-Korn SD; Cohen OS; Elincx-Benizri S; Yahalom G; Kozlova E; Strauss H; Molshatzki N; Inzelberg R; Spiegelmann R; Israel Z; Hassin-Baer S
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1053-6. PubMed ID: 23932063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease.
    Liang GS; Chou KL; Baltuch GH; Jaggi JL; Loveland-Jones C; Leng L; Maccarone H; Hurtig HI; Colcher A; Stern MB; Kleiner-Fisman G; Simuni T; Siderowf AD
    Stereotact Funct Neurosurg; 2006; 84(5-6):221-7. PubMed ID: 17063043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative Confusion in Patients with Parkinson Disease Undergoing Deep Brain Stimulation of the Subthalamic Nucleus.
    Paim Strapasson AC; Martins Antunes ÁC; Petry Oppitz P; Dalsin M; de Mello Rieder CR
    World Neurosurg; 2019 May; 125():e966-e971. PubMed ID: 30763744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subthalamic nucleus deep brain stimulation in elderly patients--analysis of outcome and complications.
    Vesper J; Haak S; Ostertag C; Nikkhah G
    BMC Neurol; 2007 Mar; 7():7. PubMed ID: 17367531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative symptoms of psychosis after deep brain stimulation in patients with Parkinson's disease.
    Qureshi AA; Cheng JJ; Sunshine AN; Wu A; Pontone GM; Cascella N; Lenz FA; Grill SE; Anderson WS
    Neurosurg Focus; 2015 Jun; 38(6):E5. PubMed ID: 26030705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age Limits for Deep Brain Stimulation of Subthalamic Nuclei in Parkinson's Disease.
    Bouwyn JP; Derrey S; Lefaucheur R; Fetter D; Rouille A; Le Goff F; Maltête D
    J Parkinsons Dis; 2016 Apr; 6(2):393-400. PubMed ID: 27061064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease.
    Fabbri M; Coelho M; Guedes LC; Rosa MM; Abreu D; Gonçalves N; Antonini A; Ferreira JJ
    Parkinsonism Relat Disord; 2017 Aug; 41():113-117. PubMed ID: 28528805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease.
    Martinez-Fernandez R; Pelissier P; Quesada JL; Klinger H; Lhommée E; Schmitt E; Fraix V; Chabardes S; Mertens P; Castrioto A; Kistner A; Broussolle E; Pollak P; Thobois S; Krack P
    J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):311-8. PubMed ID: 25934016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.